• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthCDC

A Little-Known Program Explains Why the New CDC Director Earns Twice as Much as His Predecessor

By
Hallie Detrick
Hallie Detrick
Down Arrow Button Icon
By
Hallie Detrick
Hallie Detrick
Down Arrow Button Icon
April 24, 2018, 7:40 AM ET
Robert-Redfield-CDC-Director
This undated photo provided by the University of Maryland School of Medicine in March 2018 shows Dr. Robert Redfield Jr. Photograph by Tracey Brown—University of Maryland School of Medicine/APTracey Brown—University of Maryland School of Medicine/AP

The new director of the Centers for Disease Control and Prevention (CDC), Dr. Robert Redfield Jr., has no experience working in public health or managing a public health agency, but he’s getting paid at least $150,000 more per year than any of his predecessors.

Redfield’s salary falls under a program called Title 42, which is intended to attract top scientists with essential skills to public service by edging a bit closer to the salaries they could expect to make in the private sector. Thousands of workers at the CDC and National Institutes of Health (NIH) are paid under Title 42.

Still, it is unusual to pay a CDC director—or a director of other national health agencies—under this program. Redfield’s $375,000 annual salary is much higher than the salaries of his peers. Dr. Francis Collins of NIH earns $199,700 per year and Dr. Scott Gottlieb of the Food and Drug Administration (FDA) earns $155,500. Redfield’s pay is higher than the $197,300 annual salary his predecessor earned during her six-month tenure. He even earns more than his boss Secretary of the Department of Health and Human Services Alex Azar.

The salaries for Gottlieb, Collins, and Azar are set by law and therefore not eligible for Title 42. It is unclear why Redfield’s salary was determined under Title 42 while those of his predecessors were not.

Before assuming his new position, Redfield was a medical professor at the University of Maryland. He has conducted extensive research on HIV/AIDS and sought the position of CDC director for a decade. His appointment has drawn criticism because of his inexperience with public health organizations and because he has held controversial opinions about AIDS.

About the Author
By Hallie Detrick
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.